Form 8-K - Current report:
SEC Accession No. 0000805928-23-000049
Filing Date
2023-05-09
Accepted
2023-05-09 07:18:10
Documents
14
Period of Report
2023-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K axgn-20230509.htm   iXBRL 8-K 33887
2 EX-99.1 a991axgnreleasedatedmay920.htm EX-99.1 215520
6 image_0.jpg GRAPHIC 30876
  Complete submission text file 0000805928-23-000049.txt   444861

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axgn-20230509.xsd EX-101.SCH 1905
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axgn-20230509_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axgn-20230509_pre.xml EX-101.PRE 12510
8 EXTRACTED XBRL INSTANCE DOCUMENT axgn-20230509_htm.xml XML 10642
Mailing Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615
Business Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615 (386) 462-6817
Axogen, Inc. (Filer) CIK: 0000805928 (see all company filings)

EIN.: 411301878 | State of Incorp.: MN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36046 | Film No.: 23899960
SIC: 3845 Electromedical & Electrotherapeutic Apparatus